Answers are grounded in this paper and cite their sources.
Distinguishing acquired demyelinating neuropathies by phenotype can often predict the presence of IgM kappa M-proteins, anti-MAG antibodies, and responses to immunomodulating therapy.
No takes yet. Share an insight, caveat, or question.
Katz et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: